Status of oxidative stress in breast cancer patients in Pakistani population

Sara Javed, Muhammad Ali, Fatima Ali, Sanam Saiqa Anwar, Nadia Wajid

Abstract


Background: Breast cancer is a major risk factor to the health of women around the globe and every year more than one million women are diagnosed with it. Pakistan is considered on the highest risk of breast cancer among Asian countries. One of the major reasons associated with higher incidence rate is oxidative stress condition in Pakistani women. The aim of this study was to analyze oxidative stress in patients with breast cancer in local population.

Methods: Activity of antioxidant enzymes i.e. superoxide dismutase (SOD) and catalase, level of reduced glutathione (GSH) were measured in the blood samples of breast cancer patients. To emphasize the results and the extent of lipid peroxidation in terms of malonyl dialdehyde (MDA) level were also evaluated. All the activities from cancer patients were compared with those of healthy people taken as control.

Results: The levels of GSH and MDA were found higher in the patients as compared to control group. While, activity of SOD and catalase enzymes was low in the diseased group.

Conclusion: Our study shows a significant oxidative stress in breast cancer patients in local population.


Full Text:

PDF

References


Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA: A Cancer Journal for Clinicians, (2014); 64(1): 9-29.

Benson JR, Jatoi I, Keisch M, Esteva FJ, Makris A, et al. Early breast cancer. The Lancet, (2009); 373(9673): 1463-1479.

Cindrova-Davies T, Yung H-W, Johns J, Spasic-Boskovic O, Korolchuk S, et al. Oxidative stress, gene expression, and protein changes induced in the human placenta during labor. The American Journal of Pathology, (2007); 171(4): 1168-1179.

Ruder EH, Hartman TJ, Goldman MB. Impact of oxidative stress on female fertility. Current Opinion in Obstetrics & Gynecology, (2009); 21(3): 219.

Tas F, Hansel H, Belce A, Ilvan S, Argon A, et al. Oxidative stress in breast cancer. Medical Oncology, (2005); 22(1): 11-15.

Rockenbach G, Di Pietro P, Ambrosi C, Boaventura B, Vieira F, et al. Dietary intake and oxidative stress in breast cancer: before and after treatments. Nutrición Hospitalaria, (2011); 26(4): 737-744.

Tesarova P, Kalousová M, Trnková B, Soukupová J, Argalásová S, et al. Carbonyl and oxidative stress in patients with breast cancer--is there a relation to the stage of the disease? Neoplasma, (2006); 54(3): 219-224.

Sotgia F, Martinez-Outschoorn UE, Lisanti MP. Mitochondrial oxidative stress drives tumor progression and metastasis: should we use antioxidants as a key component of cancer treatment and prevention? BMC Medicine, (2011); 9(1): 62.

Mahajan M, Tiwari N, Sharma R, Kaur S, Singh N. Oxidative Stress and Its Relationship With Adenosine Deaminase Activity in Various Stages of Breast Cancer. Indian Journal of Clinical Biochemistry, (2013); 28(1): 51-54.

Klaunig JE, Kamendulis LM, Hocevar BA. Oxidative stress and oxidative damage in carcinogenesis. Toxicologic pathology, (2010); 38(1): 96-109.

Weydert CJ, Cullen JJ. Measurement of superoxide dismutase, catalase and glutathione peroxidase in cultured cells and tissue. Nature Protocols, (2010); 5(1): 51-66.

Wajid N, Naseem R, Anwar SS, Awan SJ, Ali M, et al. The effect of gestational diabetes on proliferation capacity and viability of human umbilical cord-derived stromal cells. Cell and Tissue Banking, (2014); 1-9.

Amin KA, Mohamed BM, El-Wakil MAM, Ibrahem SO. Impact of breast cancer and combination chemotherapy on oxidative stress, hepatic and cardiac markers. Journal of Breast Cancer, (2012); 15(3): 306-312.

Traverso N, Ricciarelli R, Nitti M, Marengo B, Furfaro AL, et al. Role of glutathione in cancer progression and chemoresistance. Oxidative medicine and cellular longevity, (2013); 2013.

Ghalia AHA, Fouad IM. Glutathione and its metabolizing enzymes in patients with different benign and malignant diseases. Clinical Biochemistry, (2000); 33(8): 657-662.

Kumaraguruparan R, Subapriya R, Kabalimoorthy J, Nagini S. Antioxidant profile in the circulation of patients with fibroadenoma and adenocarcinoma of the breast. Clinical Biochemistry, (2002); 35(4): 275-279.

Negahdar M, Djalali M, Abtahi H, Sadeghi M, Aghvami T, et al. Blood superoxide dismutase and catalase activities in women affected with breast cancer. Iranian Journal of Public Health, (2005); 34(3): 39-43.

Guo C-H, Hsia S, Chen P-C. Distribution of selenium and oxidative stress in breast tumor-bearing mice. Nutrients, (2013); 5(2): 594-607.


Refbacks

  • There are currently no refbacks.